Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2010 6
2011 5
2012 6
2013 1
2014 8
2015 10
2016 10
2017 9
2018 30
2019 54
2020 27
2021 27
2022 30
2023 16
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Results by year

Filters applied: . Clear all
Page 1
Plazomicin.
[No authors listed] [No authors listed] 2021 Aug 16. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2021 Aug 16. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000983 Free Books & Documents. Review.
Plazomicin is an aminoglycoside antibiotic similar to gentamicin and amikacin. No information is available on the use of plazomicin during breastfeeding. However, based on the excretion of other aminoglycoside antibiotics, amounts in milk are expected to be low. ...
Plazomicin is an aminoglycoside antibiotic similar to gentamicin and amikacin. No information is available on the use of plazomici …
Plazomicin.
[No authors listed] [No authors listed] 2019 Apr 12. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2019 Apr 12. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643858 Free Books & Documents. Review.
Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis. Plazomicin has had limited clinical use but has not been linked to serum enzyme elevations during th …
Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tra …
Plazomicin: A New Aminoglycoside.
Saravolatz LD, Stein GE. Saravolatz LD, et al. Clin Infect Dis. 2020 Feb 3;70(4):704-709. doi: 10.1093/cid/ciz640. Clin Infect Dis. 2020. PMID: 31328228 Review.
Plazomicin (ACHN-490) is a novel parenteral aminoglycoside developed to target multidrug-resistant Enterobacteriaceae. It has recently been approved by the Food and Drug Administration for the management of complicated urinary tract infections and pyelonephritis caused by …
Plazomicin (ACHN-490) is a novel parenteral aminoglycoside developed to target multidrug-resistant Enterobacteriaceae. It has recentl …
Plazomicin: A Next-Generation Aminoglycoside.
Shaeer KM, Zmarlicka MT, Chahine EB, Piccicacco N, Cho JC. Shaeer KM, et al. Pharmacotherapy. 2019 Jan;39(1):77-93. doi: 10.1002/phar.2203. Epub 2019 Jan 8. Pharmacotherapy. 2019. PMID: 30511766 Review.
In a large phase III clinical trial, plazomicin was shown to be noninferior to meropenem in the treatment of complicated urinary tract infections (cUTIs) with respect to the coprimary efficacy end points of the microbiologically modified intent-to-treat composite cure rate …
In a large phase III clinical trial, plazomicin was shown to be noninferior to meropenem in the treatment of complicated urinary trac …
Plazomicin against Multidrug-Resistant Bacteria: A Scoping Review.
Alfieri A, Di Franco S, Donatiello V, Maffei V, Fittipaldi C, Fiore M, Coppolino F, Sansone P, Pace MC, Passavanti MB. Alfieri A, et al. Life (Basel). 2022 Nov 22;12(12):1949. doi: 10.3390/life12121949. Life (Basel). 2022. PMID: 36556314 Free PMC article. Review.
Plazomicin is a next-generation semisynthetic aminoglycoside antibiotic that can be used to treat infections by multi-resistant bacteria. ...The pathogens killed included multi-resistant E. coli, K. pneumoniae, A. baumannii, P. aeruginosa, and S. aureus. Plazomicin …
Plazomicin is a next-generation semisynthetic aminoglycoside antibiotic that can be used to treat infections by multi-resistant bacte …
Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial Infections.
Eljaaly K, Alharbi A, Alshehri S, Ortwine JK, Pogue JM. Eljaaly K, et al. Drugs. 2019 Feb;79(3):243-269. doi: 10.1007/s40265-019-1054-3. Drugs. 2019. PMID: 30723876 Review.
Plazomicin is a novel semisynthetic parenteral aminoglycoside that inhibits bacterial protein synthesis. ...Plazomicin has been assessed in two phase III randomized controlled trials. ...
Plazomicin is a novel semisynthetic parenteral aminoglycoside that inhibits bacterial protein synthesis. ...Plazomicin has bee …
Plazomicin-associated Nephrotoxicity.
Tang HJ, Lai CC. Tang HJ, et al. Clin Infect Dis. 2020 Aug 14;71(4):1130-1131. doi: 10.1093/cid/ciz1064. Clin Infect Dis. 2020. PMID: 31665240 No abstract available.
Plazomicin: a new aminoglycoside in the fight against antimicrobial resistance.
Clark JA, Burgess DS. Clark JA, et al. Ther Adv Infect Dis. 2020 Sep 4;7:2049936120952604. doi: 10.1177/2049936120952604. eCollection 2020 Jan-Dec. Ther Adv Infect Dis. 2020. PMID: 32953108 Free PMC article. Review.
DATA SOURCES: A PubMed search was performed from January 2006 to August 2019 using the following search terms: plazomicin and ACHN-490. Another search was conducted on clinicaltrials.gov for published clinical data. ...CONCLUSIONS: Plazomicin appears poised to help …
DATA SOURCES: A PubMed search was performed from January 2006 to August 2019 using the following search terms: plazomicin and ACHN-49 …
Plazomicin: an intravenous aminoglycoside antibacterial for the treatment of complicated urinary tract infections.
Bilinskaya A, Linder KE, Kuti JL. Bilinskaya A, et al. Expert Rev Anti Infect Ther. 2020 Aug;18(8):705-720. doi: 10.1080/14787210.2020.1759419. Epub 2020 May 13. Expert Rev Anti Infect Ther. 2020. PMID: 32319833 Review.
The information discussed is meant to assist in identifying plazomicin's place in therapy and to expand the clinician's armamentarium. ...Search terms used include plazomicin, ACHN-490, extended spectrum ss-lactamase, ESBL, CRE, aminoglycoside modifying enzymes, and …
The information discussed is meant to assist in identifying plazomicin's place in therapy and to expand the clinician's armamentarium …
Plazomicin for the treatment of patients with complicated urinary tract infection.
McCarthy MW. McCarthy MW. Drugs Today (Barc). 2018 Sep;54(9):513-518. doi: 10.1358/dot.2018.54.9.2874063. Drugs Today (Barc). 2018. PMID: 30303492 Review.
In June 2018, the United States Food and Drug Administration (FDA) approved plazomicin, a novel neoglycoside, for the treatment of adults with complicated urinary tract infections who have limited or no alternative treatment options. ...This manuscript reviews the in vivo …
In June 2018, the United States Food and Drug Administration (FDA) approved plazomicin, a novel neoglycoside, for the treatment of ad …
220 results